ketamine has been researched along with Smoking Cessation in 3 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Smoking Cessation: Discontinuing the habit of SMOKING.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alcohol use disorder is prevalent globally and in Kenya, and is associated with significant health and socio-economic consequences." | 1.91 | Intravenous ketamine for severe alcohol use disorder at Moi Teaching & Referral Hospital, Kenya: a case report. ( Andale, T; Aruasa, WK; Gakinya, B; Jaguga, F; Kerema, J; Kinyanjui, D; Kirwa, P; Kwobah, C; Kwobah, EK; Manji, I; Mwangi, F; Songok, J; Temet, E; Werunga, K, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jaguga, F | 1 |
| Kirwa, P | 1 |
| Gakinya, B | 1 |
| Manji, I | 1 |
| Andale, T | 1 |
| Kinyanjui, D | 1 |
| Kwobah, EK | 1 |
| Mwangi, F | 1 |
| Werunga, K | 1 |
| Kerema, J | 1 |
| Kwobah, C | 1 |
| Temet, E | 1 |
| Songok, J | 1 |
| Aruasa, WK | 1 |
| Post, RM | 1 |
| Yatham, LN | 1 |
| Vieta, E | 1 |
| Berk, M | 1 |
| Nierenberg, AA | 1 |
| Salih, H | 1 |
| Anghelescu, I | 1 |
| Kezic, I | 1 |
| Sinha, V | 1 |
| Hoeben, E | 1 |
| Van Nueten, L | 1 |
| De Smedt, H | 1 |
| De Boer, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Double-Blind, 2-Way Crossover Study to Investigate the Effects of JNJ-40411813 on Ketamine-Induced Alterations in Neuropsychiatric Performance[NCT01101659] | Phase 1 | 40 participants (Actual) | Interventional | 2010-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ketamine and Smoking Cessation
| Article | Year |
|---|---|
Beyond evidence-based treatment of bipolar disorder: Rational pragmatic approaches to management.
Topics: Ankyrins; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Anxiety Disorders; Bipolar Disord | 2019 |
1 trial available for ketamine and Smoking Cessation
| Article | Year |
|---|---|
Pharmacokinetic and pharmacodynamic characterisation of JNJ-40411813, a positive allosteric modulator of mGluR2, in two randomised, double-blind phase-I studies.
Topics: Administration, Oral; Adolescent; Adult; Allosteric Regulation; Attention; Cognition; Dose-Response | 2015 |
1 other study available for ketamine and Smoking Cessation
| Article | Year |
|---|---|
Intravenous ketamine for severe alcohol use disorder at Moi Teaching & Referral Hospital, Kenya: a case report.
Topics: Adult; Alcoholism; Hospitals; Humans; Kenya; Ketamine; Male; Naltrexone; Referral and Consultation; | 2023 |